Home  >  Products  >  Kcnj3 (potassium inwardly-rectifying channel, subfamily J, member 3 ) Blocking Peptide (the C terminal of Kcnj3)(100ug)
Kcnj3 (potassium inwardly-rectifying channel, subfamily J, member 3 ) Blocking Peptide (the C terminal of Kcnj3)(100ug)

Kcnj3 (potassium inwardly-rectifying channel, subfamily J, member 3 ) Blocking Peptide (the C terminal of Kcnj3)(100ug)

Supplier: Aviva Systems Biology Incorporated
Star_fadedStar_fadedStar_fadedStar_fadedStar_faded
0 reviews | Write a Review Pencil
This is a synthetic peptide designed for use in combination with anti-Kcnj3 Antibody (ARP35081_P050), made by Aviva Systems Biology. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
Reactivities: Mouse
Presku: AAP35081
Size: 100ug
Weight: 56kDa
Gene: The peptide is characterized by mass spectroscopy
Format: Lyophilized powder
Target: This potassium channel is controlled by G proteins. Inward rectifier potassium channels are characterized by a greater tendency to allow potassium to flow into the cell rather than out of it. Their voltage dependence is regulated by the concentration of extracellular potassium; as external potassium is raised, the voltage range of the channel opening shifts to more positive voltages. The inward rectification is mainly due to the blockage of outward current by internal magnesium. This receptor plays a crucial role in regulating the heartbeat.
Alternative names: GIRK1; Kcnf3; Kir3.1; MGC124233; MGC124234
See Full Product Listings >